Marinomed Biotech AG
Develops treatments for viral infectious diseases and immunological disorders.
MARI | VI
Overview
Corporate Details
- ISIN(s):
- ATMARINOMED6
- LEI:
- 529900GN3B1EN80XF405
- Country:
- Austria
- Address:
- Hovengasse 25, 2100 Korneuburg
- Website:
- https://www.marinomed.com/en
- Sector:
- Manufacturing
Description
Marinomed Biotech AG is a biopharmaceutical company that develops medicinal products and medical devices for viral infectious diseases and immunological disorders. The company's innovation is driven by proprietary, patent-protected technology platforms. The Marinosolv platform enhances the solubility and bioavailability of poorly soluble compounds, enabling the development of treatments for immunological conditions such as allergies, asthma, and inflammatory diseases. The virology platform is the basis for therapies targeting viral respiratory infections. Marinomed maintains a development pipeline, has globally marketed therapeutics, and offers its technology through partnerships and services via its Solv4U unit.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-19 12:39 |
Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelos…
|
English | 9.7 KB | ||
| 2024-12-18 13:00 |
Marinomed Biotech AG: Requirements for successful completion of the restructuri…
|
English | 10.4 KB | ||
| 2024-12-17 13:00 |
Marinomed Biotech AG: Requirements for successful completion of the restructuri…
|
English | 10.4 KB | ||
| 2024-12-06 14:34 |
Marinomed Biotech AG resolves second capital increase excluding statutory subsc…
|
English | 5.7 KB | ||
| 2024-12-05 14:34 |
Marinomed Biotech AG resolves second capital increase excluding statutory subsc…
|
English | 5.7 KB | ||
| 2024-11-29 11:04 |
Marinomed Biotech AG: Invitation to an Extraordinary General Meeting on Thursda…
|
English | 28.1 KB | ||
| 2024-11-28 13:34 |
Marinomed Biotech AG: Binding Term Sheet for the intended issuance of a convert…
|
English | 5.5 KB | ||
| 2024-11-28 11:06 |
EQS-AGM: Marinomed Biotech AG: Invitation to an Extraordinary General Meeting o…
|
English | 56.9 KB | ||
| 2024-11-28 11:05 |
EQS-HV: Marinomed Biotech AG: Einberufung einer außerordentlichen Hauptversamml…
|
German | 51.4 KB | ||
| 2024-11-27 21:14 |
Marinomed Biotech AG signs agreement for sale of Carragelose business to French…
|
English | 5.3 KB | ||
| 2024-11-27 13:35 |
EQS-Adhoc: Marinomed Biotech AG: Binding Term Sheet for the intended issuance o…
|
English | 21.4 KB | ||
| 2024-11-27 13:35 |
EQS-Adhoc: Marinomed Biotech AG: Bindendes Term Sheet für beabsichtigte Ausgabe…
|
German | 21.8 KB | ||
| 2024-11-27 12:51 |
EQS-Adhoc: Marinomed Biotech AG: Publication of a report on the exclusion of su…
|
English | 33.9 KB | ||
| 2024-11-27 12:51 |
EQS-Adhoc: Marinomed Biotech AG: Veröffentlichung eines Berichts zum Bezugsrech…
|
German | 34.8 KB | ||
| 2024-11-26 21:16 |
EQS-Adhoc: Marinomed Biotech AG signs agreement for sale of Carragelose busines…
|
English | 24.6 KB |
Automate Your Workflow. Get a real-time feed of all Marinomed Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Marinomed Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Marinomed Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
